1. Home
  2. News
  3. Kexing Biopharm Co., Ltd.
  4. Announcement on Preliminary Earnings Estimate for 2025
More Kexing Biopharm Co., Ltd. news
Kexing Biopharm Co., Ltd.SSE: 688136

Announcement on Preliminary Earnings Estimate for 2025

Feb 28, 2026 · Issued by Kexing Biopharm Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Feb 28, 2026 · 3 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-preliminary-earnings-estimate-for-2025-87

Kexing Biopharm Co., Ltd. on 6ix

Earlier from Kexing Biopharm

  • Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of GB19 InjectionFeb 26
  • Announcement on Progress in Repurchasing Shares through Call AuctionFeb 4
  • Earnings Preannouncement for 2025Jan 31
  • Announcement on Estimated Amount of Daily Related Transactions in 2026Jan 1
  • Announcement on Renewing Engagement of Accounting FirmDec 16, 2025

Later from Kexing Biopharm

  • Announcement on Signing Daily Related Party Transaction AgreementsMar 3
  • Announcement on Progress and Implementation Result of Shares Repurchase and Share ChangesMar 4
  • Announcement on Opening a Special Account for Raised Funds and Signing a Tripartite Supervision Agreement on Special Account Deposit of Raised FundsMar 21
  • Announcement on Voluntary Disclosure of GB19 Injection Obtaining FDA Clinical Trial Approval for New DrugsMar 31
  • 2025 Annual ReportApr 22
All Kexing Biopharm news releases↗

Follow Kexing Biopharm into a list and get an email when it puts out news.

Follow Kexing Biopharm
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer